Iterum Therapeutics (ITRM) Interest & Investment Income (2017 - 2022)
Historic Interest & Investment Income for Iterum Therapeutics (ITRM) over the last 6 years, with Q4 2022 value amounting to $80000.0.
- Iterum Therapeutics' Interest & Investment Income rose 11036.27% to $80000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was -$2.4 million, marking a year-over-year increase of 5748.24%. This contributed to the annual value of -$2.5 million for FY2024, which is 24645.76% down from last year.
- Latest data reveals that Iterum Therapeutics reported Interest & Investment Income of $80000.0 as of Q4 2022, which was up 11036.27% from -$636000.0 recorded in Q3 2022.
- In the past 5 years, Iterum Therapeutics' Interest & Investment Income registered a high of $85000.0 during Q1 2018, and its lowest value of -$4.2 million during Q4 2020.
- Moreover, its 5-year median value for Interest & Investment Income was -$701000.0 (2022), whereas its average is -$1.2 million.
- Per our database at Business Quant, Iterum Therapeutics' Interest & Investment Income crashed by 291851.85% in 2020 and then soared by 11036.27% in 2022.
- Quarter analysis of 5 years shows Iterum Therapeutics' Interest & Investment Income stood at -$326000.0 in 2018, then decreased by 24.54% to -$406000.0 in 2019, then plummeted by 945.07% to -$4.2 million in 2020, then soared by 81.81% to -$772000.0 in 2021, then soared by 110.36% to $80000.0 in 2022.
- Its last three reported values are $80000.0 in Q4 2022, -$636000.0 for Q3 2022, and -$766000.0 during Q2 2022.